RecallDepth
Class III Terminated

Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-count bottles, Distributed by: GlaxoSmithKline Consumer Healthcare, L.P., Moon Twp, PA 15108, UPC 3 0088-1175-47 8.

Company
Sanofi-Aventis U.S. Llc
Recall Initiated
June 12, 2017
Posted
July 5, 2017
Recall Number
D-0926-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
2980 bottles
Firm Location
Bridgewater, NJ, United States

Reason for Recall

Superpotent Drug: high out-of-specification result for magnesium.

Distribution

Nationwide in the USA, Puerto Rico, and the United Kingdom.

Lot / Code Info

Lot #: 5J69A, Exp 02/19; 6GF2A, 6GF3A, Exp 08/19

More recalls by Sanofi-Aventis U.S. Llc

View all recalls by this company →

Other recent Class III Drug recalls